SL-401

· Stemline Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SL-401, covering 2023-11-09 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm [Phase 2]